OpenAI CEO Sam Altman took the technology world by surprise on Thursday with the release of Operator, his company's first AI ...

Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin ...

Altman and Musk were OpenAI’s founding co-chairs in 2015, but their relationship has devolved into name-calling and lawsuits.

Elon Musk is clashing with OpenAI CEO Sam Altman over the Stargate artificial intelligence infrastructure project touted by ...

Tensions between technology leaders Elon Musk and OpenAI CEO Sam Altman were on full display this week after the Tesla CEO ...

President Donald Trump spoke with OpenAI CEO Sam Altman by phone Friday, ahead of the AI infrastructure announcement, CNBC ...

DeepSeek R1, the surprisingly efficient and powerful Chinese AI model, has taken the technology industry by storm and is rattling nerves on Wall Street.

DeepSeek’s latest models, created by a small company with limited resources, are already beating many of the leading AI ...

Tech stocks tumbled as Chinese AI startup DeepSeek's advances raised fears of intensified competition, shaking investor ...

OpenAI CEO Sam Altman took the technology world by surprise on Thursday with the release of Operator, his company’s first AI agent that can act autonomously on the web. But OpenAI is not Altman ...

Retro Biosciences Inc., a startup using artificial intelligence to discover new drugs, is reportedly raising $1 billion in ...

The Stargate project has big implications for U.S. AI leadership, but also for who's winning the new president's ear.